Baloxavir Marboxil | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Baloxavir Marboxil
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Baloxavir Marboxil

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 4 USDMF, 3 KDMF, 3 NDC API, 23 Listed Suppliers, $ API Reference Price

27 API Suppliers
4 USDMF
3 KDMF
3 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

7 FDF Dossiers, 6 FDA Orange Book, 1 Canada

7 FDF Dossiers
6 FDA Orange Book
1 Canada

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 54 News #PharmaBuzz

1 Data Compilation #PharmaFlow
54 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Annual Reports

1 US Medicaid Prescriptions
1 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

66 US Patents, 4 US Exclusivities, 9 Health Canada Patents

66 US Patents
4 US Exclusivities
9 Health Canada Patents

$ API Ref.Price (USD/KG) : 15,946 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

9 All

01 3Gowling WLG

02 6Gowling WLG (Canada) LLP

filter Patent Reset all filters

9 All

01 32812363

02 32984130

03 33033180

filter Product Reset all filters

9 All

01 9BALOXAVIR MARBOXIL

filter Dosage Reset all filters

9 All

01 9TABLET

filter Exp Date Reset all filters

9 All

01 32031-09-21

02 32036-04-27

03 32037-08-09

Product Main Page

01

Gowling WLG (Canada) LLP

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2812363

Filing Date : 2011-09-21

Strength per Unit : 20mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2812363

Filing Date : 2011-09-21

Strength per Unit : 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2984130

Filing Date : 2016-04-27

Strength per Unit : 20mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 3033180

Filing Date : 2017-08-09

Strength per Unit : 20mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG (Canada) LLP

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2984130

Filing Date : 2016-04-27

Strength per Unit : 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 3033180

Filing Date : 2017-08-09

Strength per Unit : 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gowling WLG (Canada) LLP

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2812363

Filing Date : 2011-09-21

Strength per Unit : 80mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Gowling WLG (Canada) LLP

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2984130

Filing Date : 2016-04-27

Strength per Unit : 80mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Gowling WLG

BALOXAVIR MARBOXIL

World Drug Safety EU

Not Confirmed

Gowling WLG

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 3033180

Filing Date : 2017-08-09

Strength per Unit : 80mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!